In vitro Measured Indoleamine 2, 3-dioxygenase Activity Correlates with Inflammation and Tryptophan Levels In vivo
Journal Title: International Neuropsychiatric Disease Journal - Year 2014, Vol 2, Issue 5
Abstract
Aims: To evaluate the diagnostic validity of an in vitro assay for indoleamine 2,3-dioxygenase (IDO) activity as indicator for biological alterations that are associated with depressive symptomatologies. Study Design: Retrospective evaluation of a medical database. Place and Duration of Study: Institute for Medical Diagnostics, Berlin, between April and July 2013. Methodology: We compared values for IDOin vitro, a so far unpublished assay for IDO activity that measures tryptophan degradation in peripheral blood monocytic cell (PBMC), with blood levels of tryptophan and tumor necrosis factor alpha (TNF-alpha). Values were derived from a clinical database comprising 441 patients who had received IDOin vitro, tryptophan and/or TNF-alpha testing in the course of medical treatment between May 2011 and March 2013. All data was anonymized. Clinical significance of IDOin vitro was evaluated by correlation of IDOin vitro to blood tryptophan and TNF-alpha α levels. Further, we challenged the validity of the IDOin vitro assay by investigating the influence of the PBMC proliferation rate as a potential confounding factor and comparing the responses to phythemagglutinin (PHA) and interferon-gamma (IFN-gamma), a recognized inducer of IDO activity. Results: Low plasma tryptophan and high serum TNF-alpha are associated with increased IDOin vitro (2.8±3.3 vs. 2.2±1.1, P=0.04 and 2.7±3.5 vs. 2.1±1.6, P=0.05). Elevated IDOin vitro is not due to increased PBMC proliferation rates. PHA and IFN-gamma yield correlating IDOin vitro values (correlation coefficient=0.91). Conclusions: IDOin vitro represents a valid diagnostic tool for IDO activity and correlates with inflammation and decreased availability of tryptophan in vivo. IDOin vitro may therefore serve as a biomarker to examine the interaction of inflammation and tryptophan metabolism that underlies a subgroup of depressive symptomatologies.
Authors and Affiliations
Katrin Huesker, Jana Schenk, Stefan Albrecht, Imad Lahdou, Volker von Baehr
Keywords
Related Articles
- EP ID EP241541
- DOI 10.9734/INDJ/2014/9065
- Views 133
- Downloads 0
Brain-Derived Neurotrophic Factor, Copper, Zinc and High Density Lipoprotein (HDL) in Patients with Dementia
The levels of BDNF, copper, zinc and common blood tests of two different groups of patients were considered: those with dementia syndrome and healthy older people. It would be premature to conclude that these indicators,...
Gender, Age and Class in School Differences in Internet Addiction and Psychological Distress among Adolescents in a Nigerian Urban City
Background: Reports had revealed that internet addiction is a newly emerging social and mental health issue among the youths and has attracted much attention around the world. Furthermore excessive use of the internet ha...
Psychological Predictors of Premenstrual Syndrome
Background: Premenstrual syndrome (PMS) is one the most common gynecological conditions that can impact an individual’s interpersonal relationships, social interactions, academic performance, and emotional well-being. O...
Subjective Experiences of Antipsychotic Treatment: A Comparison of First- and Second-generation Medications among Patients with Schizophrenia
Aims: The patient’s perspective of antipsychotic treatment has been a relatively neglected area of research. Whether subjective experiences of antipsychotic treatment are better among patients on second-generation antips...
Familial Idiopathic Basal Ganglia Calcification (Fahr's syndrome): Initial Clinical Neuropsychiatric Presentation without Corresponding Neurological Deficit
Familial idiopathic basal ganglia calcification (FIBGC) or Fahr's syndrome is a rare disorder with various clinical presentations which can mimic - in particular - psychiatric illness. The following case is characterized...